My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 94

    1.

    Treating anemia of chronic kidney disease in the primary care setting: cardiovascular outcomes and management recommendations.

    Schmidt RJ, Dalton CL.

    Osteopath Med Prim Care. 2007 Oct 2;1:14.PMID: 17910755 [PubMed - in process]Free PMC ArticleFree textRelated citations

    2.

    Use of erythropoiesis-stimulating agents in patients with anemia of chronic kidney disease: overcoming the pharmacological and pharmacoeconomic limitations of existing therapies.

    Wish JB, Coyne DW.

    Mayo Clin Proc. 2007 Nov;82(11):1371-80. Review.PMID: 17976358 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    3.

    Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol.

    Strippoli GF; Clinical Evaluation of the DOse of Erythropoietins Study Group (C.E. DOSE).

    Trials. 2010 Jun 9;11:70.PMID: 20534124 [PubMed - in process]Free PMC ArticleFree textRelated citations

    4.

    [Anemia in chronic kidney disease and its cardiovascular implications]

    Cases A, Coll E, Collado S.

    Med Clin (Barc). 2009 May;132 Suppl 1:38-42. Spanish. PMID: 19460479 [PubMed - indexed for MEDLINE]Related citations

    5.

    The controversy surrounding hemoglobin and erythropoiesis-stimulating agents: what should we do now?

    Singh AK.

    Am J Kidney Dis. 2008 Dec;52(6 Suppl):S5-13.PMID: 19010260 [PubMed - indexed for MEDLINE]Related citations

    6.

    Optimizing anemia management in hospitalized patients with end-stage renal disease.

    Heung M, Mueller BA, Segal JH.

    Ann Pharmacother. 2009 Feb;43(2):276-82. Epub 2009 Jan 13. Review.PMID: 19141655 [PubMed - indexed for MEDLINE]Related citations

    7.

    [Regarding the optimal hemoglobin target range in renal anemia]

    Maurin N.

    Med Klin (Munich). 2008 Sep 15;103(9):633-7. Epub 2008 Sep 24. Review. German. PMID: 18813886 [PubMed - indexed for MEDLINE]Related citations

    8.

    Are there implications from the Trial to Reduce Cardiovascular Events with Aranesp Therapy study for anemia management in dialysis patients?

    Berns JS.

    Curr Opin Nephrol Hypertens. 2010 Jul 1. [Epub ahead of print]PMID: 20601876 [PubMed - as supplied by publisher]Related citations

    9.

    Erythropoiesis-stimulating agents: past and future.

    Nangaku M, Fliser D.

    Kidney Int Suppl. 2007 Nov;(107):S1-3. Review.PMID: 17943137 [PubMed - indexed for MEDLINE]Related citations

    10.

    Clinical considerations and practical recommendations for the primary care practitioner in the management of anemia of chronic kidney disease.

    Basile JN.

    South Med J. 2007 Dec;100(12):1200-7. Review.PMID: 18090962 [PubMed - indexed for MEDLINE]Related citations

    11.

    Postdialysis outcomes associated with consistent anemia treatment in predialysis patients with chronic kidney disease.

    Wish JB, Nassar GM, Schulman K, del Aguila M, Provenzano R.

    Clin Nephrol. 2008 Apr;69(4):251-9.PMID: 18397699 [PubMed - indexed for MEDLINE]Related citations

    12.

    Anemia as a risk factor for chronic kidney disease.

    Iseki K, Kohagura K.

    Kidney Int Suppl. 2007 Nov;(107):S4-9. Review.PMID: 17943141 [PubMed - indexed for MEDLINE]Related citations

    13.

    Timing of erythropoiesis-stimulating agent initiation and adverse outcomes in nondialysis CKD: a propensity-matched observational study.

    Seliger S, Fox KM, Gandra SR, Bradbury B, Hsu VD, Walker L, Chiou CF, Fink JC.

    Clin J Am Soc Nephrol. 2010 May;5(5):882-8. Epub 2010 Mar 18.PMID: 20299377 [PubMed - in process]Related citations

    14.

    The treatment of anemia in chronic kidney disease: understandings in 2006.

    Levin A.

    Curr Opin Nephrol Hypertens. 2007 May;16(3):267-71. Review.PMID: 17420672 [PubMed - indexed for MEDLINE]Related citations

    15.

    [Anemia as a risk factor for CKD and CVD]

    Tsuruya K, Hirakata H.

    Nippon Rinsho. 2008 Sep;66(9):1786-93. Review. Japanese. PMID: 18788410 [PubMed - indexed for MEDLINE]Related citations

    16.

    Triumph and tragedy: anemia management in chronic kidney disease.

    Novak JE, Szczech LA.

    Curr Opin Nephrol Hypertens. 2008 Nov;17(6):580-8. Review.PMID: 18941350 [PubMed - indexed for MEDLINE]Related citations

    17.

    Managing anemia in for-profit dialysis chains: when ethics and business conflict.

    Coyne DW.

    Semin Dial. 2009 Jan-Feb;22(1):18-21. Review.PMID: 19250444 [PubMed - indexed for MEDLINE]Related citations

    18.

    [Incidence and management of anemia in renal transplantation: an observational-French study]

    Choukroun G, Deray G, Glotz D, Lebranchu Y, Dussol B, Bourbigot B, Lefrançois N, Cassuto-Viguier E, Toupance O, Hacen C, Lang P, Mazouz H, Martinez F.

    Nephrol Ther. 2008 Dec;4(7):575-83. Epub 2008 Jul 30. French. PMID: 18672417 [PubMed - indexed for MEDLINE]Related citations

    19.

    Therapy with erythropoiesis-stimulating agents and renal and nonrenal outcomes.

    Agarwal AK, Singh AK.

    Heart Fail Clin. 2010 Jul;6(3):323-32.PMID: 20630407 [PubMed - in process]Related citations

    20.

    Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia.

    Leaf DE, Goldfarb DS.

    Kidney Int. 2009 Jan;75(1):15-24. Epub 2008 Aug 27. Review.PMID: 18813284 [PubMed - indexed for MEDLINE]Related citations

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...
    You are here: NCBI > Literature > PubMed
    Write to the Help Desk